|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis/ d7 H6 W- h* k2 @1 [/ Y
was to close its brain research facility in Basel, Switzerland,
0 U! t' a; z$ W0 @% ^, rthe story noted that this move closely followed similar cuts; k; E4 y$ Q3 v5 n
by rival pharmaceutical firms. As a report from the European College
# o' j8 X9 g; H) }of Neuropsychopharmacology
, _% H/ n/ B6 I/ `1 @had warned a few months earlier, the) B$ `1 i3 Y9 Z* z1 q# d. r% V
abandonment of research into new psychiatric drugs by AstraZeneca,, v8 C9 D1 R" }% L/ y/ b. j
GlaxoSmithKline6 N$ T5 L3 K" h. H; T
and others meant that “withdrawal of research
$ b0 S. l3 D& q8 ~0 V7 }resources is a withdrawal of hope for patients and their families”.
" N$ B8 E2 @% f4 D2 ~# W3 ^1 J" B b9 t9 a' \9 F
" J7 e! f. ^. O1 n" J& `$ z! N/ `: Y
回复有免费下载链接! f) V$ d- r, p+ ]( p5 O
+ S5 b0 R: z+ [& W |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
